Concepedia

Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China☆☆☆

Rong Cheng Li, Feng Xiang Li, Yan Ping Li, Qi Ming Hou, Chang Gui Li, Ya Nan Li, Fu Sheng Chen, Xue Hu, Wen Bin Su, Shu-Min Zhang

Vaccine · 2011 · 19 citations · 23 references

DOI

Concepts

References

23

Report of the Task Force on Pertussis and Pertussis Immunization—1988

James D. Cherry, Philip A. Brunell, Gerald S. Golden et al. · PEDIATRICS · 1988 · 314 citations

, , +14

Comparison of 13 Acellular Pertussis Vaccines: Adverse Reactions

Michael D. Decker, Kathryn M. Edwards, Mark C. Steinhoff et al. · PEDIATRICS · 1995 · 266 citations

, , +17

The Use of Combination Vaccines Has Improved Timeliness of Vaccination in Children

Helen Kalies, Veit Grote, Thomas Verstraeten et al. · The Pediatric Infectious Disease Journal · 2006 · 170 citations

, , +17

A Safety and Immunogenicity Comparison of 12 Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fourth Dose in 15- to 20-Month-Old Children

Michael E. Pichichero, Maria Deloria Knoll, Margaret B. Rennels et al. · PEDIATRICS · 1997 · 145 citations

, , +17

Long-term Follow-up of Swedish Children Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age Indicates the Need for a Booster Dose at 5 to 7 Years of Age

Lennart Gustafsson, Luc Hessel, Jann Storsæter et al. · PEDIATRICS · 2006 · 139 citations

, , +17